This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer. Against the motion.

Size: px
Start display at page:

Download "This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer. Against the motion."

Transcription

1 This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer Against the motion Karin Haustermans

2

3 A high sensitivity means very few false negatives: no ccr but a pcr A high specificity means very few false positives: ccr but no pcr

4 Conventional MRI for restaging of locally advanced rectal cancer Zhao et al. Dis Colon Rectum Mar;57(3): Meta-analysis 24 studies 739 patients Very low sensitivity to predict pcr! Identifying pt0 rectal cancer by MRI is not reliable

5 DCE MRI for restaging of locally advanced rectal cancer Dijkhoff et al. Eur J Radiol Oct;95: Systematic review: 19 studies, 367 patients High Ktrans pre-crt correlates with complete/good response BUT The pre-crt Ktrans reported varied substantially ( ) between studies A reduction in Ktrans after CRT is associated with response

6 DW MRI for restaging of locally advanced rectal cancer Joye et al. Radiother Oncol 2014;113(2): Systematic review: 14 studies, 856 patients Parameter N pcr Sens Spec PPV NPV Accuracy DWI ADC pre VDWI pre ADC post ΔADC post (%) VDWI post ΔVDWI post (%) qualitative QUOTE FROM THE DISCUSSION: Unfortunately, MRI lacks the specificity and PPV needed to safely select patients for a wait and see policy

7 Radiomics: the Holy Grail? T2, DWI, DCE 48 patients Single center No validation set T2 and DWI 152 and 70 patients Single center Low pcr T2 114 patients Single center No validation set AUC = 0.93 Nie et al. Clin Cancer Res Nov 1;22(21): Liu et al. Clin Cancer Res. 2017; 23(23): Horvat et al. Radiol. 2018; 287(3):

8 Joye et al. Radiother Oncol Jul;124(1): patients ypt0-1n0: 22 patients

9 Joye et al. Radiother Oncol Jul;124(1): PET DWI blood tissue Adapted threshold SUV, volume, TLG Correction for BGL 6 b-values: s/mm² ROI on b0 ADC and T2-volumetry Multiplex ELISA Inflammatory markers Micro-array analysis

10 Legend CI=Combo imaging EL=ELISA MA=Microarray 12=T1 and T2 only 13=T1 and T3 only Joye et al. Radiother Oncol Jul;124(1):

11 Joye et al. Radiother Oncol Jul;124(1): AUC 0.81 ± 0.03 AUC 0.83 ± 0.03 Using a minimum PPV of 80% resulted in prediction of ypt0-1n0 with 75% sensitivity, 94% specificity and a NPV of 92% Model CI13 selected for the Leuven Organ Preservation Trial

12 Validated MR-based model for the prediction of the response to chemoradiotherapy Bulens et al. Radiother Oncol Mar;126(3): AUC 0,88 Model based on 4 parameters: T2: Volume% & Sphere_post DWI: ADC_avg_post & ADCratio_avg Development cohort (Leuven, n = 85) Validation cohort (Utrecht, n = 55) AUC 0,88 At a positive predictive value of at least 80%, this model showed a sensitivity of 68% and a specificity of 94%.

13 Validated MR-based model for the prediction of the response to chemoradiotherapy Bulens et al. Radiother Oncol Mar;126(3): AUC 0,88 EXPERTISE! Model based on 4 parameters: T2: Volume% & Sphere_post DWI: ADC_avg_post & ADCratio_avg AUC 0,88 Development cohort (Leuven, n = 85) Validation cohort (Utrecht, n = 55) At a positive predictive value of at least 80%, this model showed a sensitivity of 68% and a specificity of 94%.

14 The biological probe

15 Maas et al. Ann Surg Oncol Nov;22(12): patients Clinical assessment: AUC 0,88 All: AUC 0,89 Clinical assessment: sens 53%; spec 97% All: sens 71%; spec 97%

16 Habr-Gama et al. Dis Col Rect ;53(12): ccr = absence of positive signs of residual disease 1. Positive sign of incomplete clinical response: Residual deep ulceration +/- necrotic center (A) Superficial ulcer, irregularity (B) 2. To be considered as incomplete clinical response: Any palpable nodule, defined by DRE, even in presence of mucosal integrity (C) Any significant stenosis impeding the rigid proctoscope from sliding through A B C

17 This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer Against the motion The low specificity means residual tumor while MRI predicted a pcr The high sensitivity means a potential valuable tool to deselect patients for organ preservation strategies

18 The story of Lohengrin, son of Parcival, knight of the Round Table and guard of the holy grail He came to save his princess! Opera by Wagner, 1848

19 And married her so that she became Regina, the Queen of MRI!

20

Multi-parametric MRI for Radiotherapy Response Prediction in Rectal Cancer

Multi-parametric MRI for Radiotherapy Response Prediction in Rectal Cancer Multi-parametric MRI for Radiotherapy Response Prediction in Rectal Cancer Dr Trang Pham Radiation Oncologist PhD Supervisors: Prof Barton, A/Prof Liney, Dr K Wong Current Status in Locally Advanced Rectal

More information

Radiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology

Radiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology Radiotherapy for rectal cancer Karin Haustermans Department of Radiation Oncology O U T L I N E RT with TME surgery? Neoadjuvant or adjuvant RT? 5 x 5 Gy or long-course CRT? RT with new drugs? Selection

More information

Rectal Cancer : Curative treatment without surgery

Rectal Cancer : Curative treatment without surgery Rectal Cancer : Curative treatment without surgery Dieter Hahnloser dieter.hahnloser@chuv.ch CHUV University Hospital Lausanne Switzerland Reasons for intervention (surgery) Cure Live longer Feel better

More information

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers Esophageal Cancer What is the value of performing PET scan routinely for staging of esophageal cancers What is the sensitivity and specificity of PET scan for metastatic lesions When should PET scan be

More information

Introduction GASTROINTESTINAL

Introduction GASTROINTESTINAL Eur Radiol (2016) 26:2118 2125 DOI 10.1007/s00330-015-4062-z GASTROINTESTINAL MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated

More information

Deppen S, et al. Annals of Thoracic Surgery 2011;92:

Deppen S, et al. Annals of Thoracic Surgery 2011;92: Deppen S, et al. Annals of Thoracic Surgery 2011;92:428-33. http://www.nationmaster.com/graph/ mor_his-mortality-histoplasmosis http://www.humirarems.com/brochure.aspx Baddley, John W., et al. Emerging

More information

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2016;48(2):567-573 Original Article http://dx.doi.org/10.4143/crt.2015.195 Open Access Endoscopic Criteria for Evaluating Tumor Stage after Preoperative

More information

Imaging Endpoints for Neoadjuvant Therapy

Imaging Endpoints for Neoadjuvant Therapy Imaging Endpoints for Neoadjuvant Therapy Sarah J Vinnicombe Clinical Senior Lecturer Ninewells Hospital and Medical School University of Dundee s.vinnicombe@dundee.ac.uk Objectives What clinical questions

More information

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? Yair Lotan, Robert S. Svatek, Arthur I. Sagalowsky Should We Screen? Prevalence 5 th most common cancer

More information

Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015

Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015 www.drjeremygrummet.com.au www.aua.com.au Mr Jeremy Grummet, Urological Surgeon MBBS, MS, FRACS Foundation 49 Men s Health Symposium August 2015 The dilemma Most men die with prostate cancer rather than

More information

Diffusion Weighted Imaging in Prostate Cancer

Diffusion Weighted Imaging in Prostate Cancer Diffusion Weighted Imaging in Prostate Cancer Disclosure Information Vikas Kundra, M.D, Ph.D. No financial relationships to disclose. Education Goals and Objectives To describe the utility of diffusion-weighted

More information

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

MR-US Fusion Guided Biopsy: Is it fulfilling expectations? MR-US Fusion Guided Biopsy: Is it fulfilling expectations? Kenneth L. Gage MD, PhD Assistant Member Department of Diagnostic Imaging and Interventional Radiology 4 th Annual New Frontiers in Urologic Oncology

More information

Interim PET Hodgkin s Disease. Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal

Interim PET Hodgkin s Disease. Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal Interim PET Hodgkin s Disease Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal Why is this a Question? Early Advanced ipet ABVD + RT ABVD Pos Neg ABVD Beacopp Escalation Salvage Deescalation Talk outline

More information

This copy is for personal use only. To order printed copies, contact Purpose: Materials and Methods: Results: Conclusion:

This copy is for personal use only. To order printed copies, contact Purpose: Materials and Methods: Results: Conclusion: This copy is for personal use only. To order printed copies, contact reprints@rsna.org Original Research n Gastrointestinal Imaging Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined

More information

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Objectives: Detection of prostate cancer the need for better imaging What

More information

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh What is Early rectal cancer? pt1t2n0m0 Predictors for LN involvement Size Depth Intramural

More information

Abdominal applications of DWI

Abdominal applications of DWI Postgraduate course, SPR San Antonio (Texas), May 14-15, 2013 Abdominal applications of DWI Rutger A.J. Nievelstein Wilhelmina Children s s Hospital, Utrecht (NL) Outline What is DWI? How to perform? Challenges

More information

Carcinoma del retto: Highlights

Carcinoma del retto: Highlights Carcinoma del retto: Highlights Stefano Cordio Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania Roma 17 Febbraio 2018 Disclosures Advisory Committee, research funding and speakers bureau

More information

Anatomic Imaging of Prostate Cancer

Anatomic Imaging of Prostate Cancer Masoom Haider, MD, FRCP(C) Professor of Radiology, University of Toronto Clinician Scientist, Ontario Institute of Cancer Research Senior Scientist, Sunnybrook Research Institute Chief, Dept of Medical

More information

Neoadjuvant treatment Evolution and Current Status

Neoadjuvant treatment Evolution and Current Status Neoadjuvant treatment Evolution and Current Status Dr Andrew See Radiation Oncologist 2017 Rectal Cancer Symposium Friday 10 th November 2017 2 1 Major Randomised Trials Supporting Neoadjuvant CRT Trial

More information

Critical reading of diagnostic imaging studies. Lecture Goals. Constantine Gatsonis, PhD. Brown University

Critical reading of diagnostic imaging studies. Lecture Goals. Constantine Gatsonis, PhD. Brown University Critical reading of diagnostic imaging studies Constantine Gatsonis Center for Statistical Sciences Brown University Annual Meeting Lecture Goals 1. Review diagnostic imaging evaluation goals and endpoints.

More information

8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET

8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment

More information

Detection, Screening and. Jelle Barentsz, Radboudumc, Nijmegen, NL

Detection, Screening and. Jelle Barentsz, Radboudumc, Nijmegen, NL Detection, Screening and Staging with mpmri Jelle Barentsz, Radboudumc, Nijmegen, NL NO CONFLICT OF INTEREST Paradigm shift Past staging TRUS-GBx ERC, MRSI invasive Current detection agressive PCa mpmri-directed

More information

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and

More information

Johannes C. Athanasios Dimopoulos

Johannes C. Athanasios Dimopoulos BrachyNext Symposium Miami Beach, USA, May 30 31, 2014 Imaging Modalities: Current Challenges and Future Directions Johannes C. Athanasios Dimopoulos Imaging Modalities: Current Challenges and Future Directions

More information

MRI and Fusion biopsies. K Sahadevan Consultant Urologist

MRI and Fusion biopsies. K Sahadevan Consultant Urologist MRI and Fusion biopsies K Sahadevan Consultant Urologist MRI in Prostate Cancer Diagnosis Traditionally used for staging purposes 70 to 90% accurate detection of extra capsular disease on MRI (cornud 2002)

More information

Colorectal Cancer and FDG PET/CT

Colorectal Cancer and FDG PET/CT Hybrid imaging in colorectal & esophageal cancer Emmanuel Deshayes IAEA WorkShop, November 2017 Colorectal Cancer and FDG PET/CT 1 Clinical background Cancer of the colon and rectum is one of the most

More information

Where are we at with organ preservation for rectal cancer? Simon Bach Queen Elizabeth Hospital Birmingham ACPGBI Edinburgh 2016

Where are we at with organ preservation for rectal cancer? Simon Bach Queen Elizabeth Hospital Birmingham ACPGBI Edinburgh 2016 Where are we at with organ preservation for rectal cancer? Simon Bach Queen Elizabeth Hospital Birmingham ACPGBI Edinburgh 2016 Disclosures Consultant for Johnson and Johnson (Ethicon Inc) Encompasses

More information

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment

More information

Successful Breast MRI Program : The ingredients

Successful Breast MRI Program : The ingredients Successful Breast MRI Program : The ingredients Dr. Smriti Hari Associate Professor Deptt. Of Radiology All India Institute of Medical Sciences New Delhi How to perform Breast MRI Breast MRI descriptors

More information

Advances in Imaging Technology In The Management of Colorectal Cancer

Advances in Imaging Technology In The Management of Colorectal Cancer Advances in Imaging Technology In The Management of Colorectal Cancer Dushyant Sahani, M.D Director of CT Associate Professor Department of Radiology Massachusetts General Hospital Harvard Medical School

More information

The Role Of The Post-CRT MRI In Assessing Response

The Role Of The Post-CRT MRI In Assessing Response Low Rectal Cancer: Is It Safe To Change The Plane Of Surgery? The Role Of The Post-CRT MRI In Assessing Response Nick Battersby, Mit Dattani, Nick West, Graham Branagan, Mark Gudgeon, Phil Quirke, Paris

More information

Prostate MRI for local staging and surgical planning in prostate cancer

Prostate MRI for local staging and surgical planning in prostate cancer Prostate MRI for local staging and surgical planning in prostate cancer 15th Annual Floyd A. Fried Advances in Urology Symposium June 23, 2017 Ray Tan, MD, MSHPM Assistant Professor Disclosures None Objectives

More information

Radiological assessment of neoadjuvent chemotherapy for breast cancer

Radiological assessment of neoadjuvent chemotherapy for breast cancer XV th Balkan Congress of Radiology Budapest, Hungary, October 12 15, 2017 Radiological assessment of neoadjuvent chemotherapy for breast cancer V. Bešlagić C l i n i c o f R a d i o l o g y, U n i v e

More information

MRI and metastases of PCa

MRI and metastases of PCa MRI and metastases of PCa François CORNUD Céline COUVIDAT David EISS Arnaud LEFEVRE IRM Paris 16, France, Paris, France Université Paris Descartes, Paris, France When imaging should be considered for detection

More information

Essential Initial Activities and Clinical Outcomes

Essential Initial Activities and Clinical Outcomes Essential Initial Activities and Clinical Outcomes Crystal Farrell 1,2 & Sabrina L. Noyes 2, Joe Joslin 2, Manish Varma 2,3, Andrew Moriarity 2,3, Christopher Buchach 2,3, Leena Mammen 2,3, Brian R. Lane

More information

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation Roberto Alonzi Mount Vernon Cancer Centre Overview Introduction and rationale for focused dose escalation

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance

More information

Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer

Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer JNCI J Natl Cancer Inst (2016) 108(12): djw171 doi: 10.1093/jnci/djw171 First published online August 10, 2016 Article Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for

More information

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department

More information

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%) Prostate MRI John Bell, MD Introduction Prostate Cancer Screening Staging Anatomy Prostate MRI overview Functional MRI Multiparametric Approach Indications Example Cases Overview Introduction Prostate

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI Personalized Medicine and Imaging Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI Ke Nie 1, Liming Shi 2, Qin Chen 2,XiHu 3, Salma K. Jabbour 1,

More information

EVALUATION OF AXILLARY LYMPH NODES AFTER NEOADJUVANT SYSTEMIC THERAPY KIM, MIN JUNG SEVERANCE HOSPITAL, YONSEI UNIVERSITY

EVALUATION OF AXILLARY LYMPH NODES AFTER NEOADJUVANT SYSTEMIC THERAPY KIM, MIN JUNG SEVERANCE HOSPITAL, YONSEI UNIVERSITY EVALUATION OF AXILLARY LYMPH NODES AFTER NEOADJUVANT SYSTEMIC THERAPY KIM, MIN JUNG SEVERANCE HOSPITAL, YONSEI UNIVERSITY AXILLARY LYMPH NODE METASTASIS Axillary lymph node metastasis is one of the most

More information

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging Poster No.: C-1766 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit J. Bae, C. K. Kim, S.

More information

Electrical impedance scanning of the breast is considered investigational and is not covered.

Electrical impedance scanning of the breast is considered investigational and is not covered. ARBenefits Approval: 09/28/2011 Effective Date: 01/01/2012 Revision Date: Code(s): Medical Policy Title: Electrical Impedance Scanning of the Breast Document: ARB0127 Administered by: Public Statement:

More information

MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND (TRUS)

MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND (TRUS) MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND 06/16/05, 05/18/06, 03/15/07, 02/21/08 PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under

More information

A biopsy can be avoided in patients with positive DRE and negative MRI. Disagree: Michael Cohen, Chairman, Dept. of Urol. Haemek M.

A biopsy can be avoided in patients with positive DRE and negative MRI. Disagree: Michael Cohen, Chairman, Dept. of Urol. Haemek M. A biopsy can be avoided in patients with positive DRE and negative MRI Disagree: Michael Cohen, Chairman, Dept. of Urol. Haemek M.C, Afula, Israel Financial and Other Disclosures Off-label use of drugs,

More information

Case Report 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response

Case Report 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response Case Reports in Surgery Volume 2015, Article ID 816491, 5 pages http://dx.doi.org/10.1155/2015/816491 Case Report 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological

More information

Syddansk Universitet. Published in: Journal of Surgical Oncology. DOI: /jso Publication date: 2017

Syddansk Universitet. Published in: Journal of Surgical Oncology. DOI: /jso Publication date: 2017 Syddansk Universitet Dual energy CT a possible new method to assess regression of rectal cancers after neoadjuvant treatment Al-Najami, Issam; Drue, Henrik Christian; Steele, Robert; Baatrup, Gunnar Published

More information

PET/CT for Therapy Assessment in Oncology

PET/CT for Therapy Assessment in Oncology PET/CT for Therapy Assessment in Oncology Rodolfo Núñez Miller, M.D. Nuclear Medicine Section Division of Human Health International Atomic Energy Agency Vienna, Austria Clinical Applications of PET/CT

More information

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ??? Disclosures No relevant financial disclosures Diffusion and Perfusion Imaging in the Head and Neck Ashok Srinivasan, MD Associate Professor Director of Neuroradiology University of Michigan Health System

More information

Developments in Directional Brachytherapy William Y. Song, PhD, DABR

Developments in Directional Brachytherapy William Y. Song, PhD, DABR Developments in Directional Brachytherapy William Y. Song, PhD, DABR Medical Physicist Dept. Radiation Oncology Massey Cancer Center Director CAMPEP Graduate Program Virginia Commonwealth University Associate

More information

Management of Squamous Cell Cancer of the Esophagus: Surgery Should Follow Chemo + RT

Management of Squamous Cell Cancer of the Esophagus: Surgery Should Follow Chemo + RT Management of Squamous Cell Cancer of the Esophagus: Surgery Should Follow Chemo + RT David H. Ilson, MD, PhD Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center Disclosure Consulting

More information

How to detect and investigate Prostate Cancer before TRT

How to detect and investigate Prostate Cancer before TRT How to detect and investigate Prostate Cancer before TRT Frans M.J. Debruyne Professor of Urology Andros Men s Health Institutes, The Netherlands Bruges, 25-26 September 2014 PRISM Recommendations for

More information

Current Trends in Pediatric GU Imaging European Perspective

Current Trends in Pediatric GU Imaging European Perspective Current Trends in Pediatric GU Imaging European Perspective Pierre-Hugues Vivier, MD, PhD CHU C. Nicolle, Rouen, France Générale de Santé, Hôpital Privé de l Estuaire, Le Havre, France 1.6% of boys / 7.8%

More information

Rx Only. Detecting Cancer In Blood.

Rx Only. Detecting Cancer In Blood. Epi procolon is an FDA-approved blood test for colorectal cancer screening for patients who are unwilling or unable to be screened by recommended methods. Rx Only Intended Use, Contraindications, Warnings,

More information

Can We Omit Surgery with Suggestion of pcr by Biopsy in Breast? Fudan University Shanghai Cancer Center Ke-Da Yu, M.D.

Can We Omit Surgery with Suggestion of pcr by Biopsy in Breast? Fudan University Shanghai Cancer Center Ke-Da Yu, M.D. Can We Omit Surgery with Suggestion of pcr by Biopsy in Breast? Fudan University Shanghai Cancer Center Ke-Da Yu, M.D. I have no relevant financial relationship with commercial interests to disclose. More

More information

Assessment of performance and decision curve analysis

Assessment of performance and decision curve analysis Assessment of performance and decision curve analysis Ewout Steyerberg, Andrew Vickers Dept of Public Health, Erasmus MC, Rotterdam, the Netherlands Dept of Epidemiology and Biostatistics, Memorial Sloan-Kettering

More information

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence. Multi-parametric MR imaging in Problems: TRUS Bx Low Risk Prostate Cancer Important cancers are missed Jelle Barentsz Clinically insignificant cancers are identified by Prostate MR Center of Excellence

More information

Local Excision of Rectal Cancer Techniques and Outcomes

Local Excision of Rectal Cancer Techniques and Outcomes Local Excision of Rectal Cancer Techniques and Outcomes Manoj J. Raval, MD, MSc, FRCSC Clinical Assistant Professor, UBC Rectal Cancer Update 2008 October 25, 2008 Overview Techniques & Description Patient

More information

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer Evidence-based utilization of imaging in prostate cancer Fergus Coakley MD, Professor of Radiology and Urology, Vice Chair for Clinical Services, Chief of Abdominal Imaging, UCSF Objectives State the modalities,

More information

Abdominal MRI in the Emergency Setting

Abdominal MRI in the Emergency Setting Abdominal MRI in the Emergency Setting Ivan Pedrosa, MD, FSCBTMR UT Southwestern Medical Center. Dallas, TX MRI Use in Tertiary Care ED (01-05) 391% increase in ED MRI (1,900 exams) 38.9% total MRI increase

More information

Utility of Prostate MRI. John R. Leyendecker, MD

Utility of Prostate MRI. John R. Leyendecker, MD Utility of Prostate MRI John R. Leyendecker, MD Professor of Radiology and Urology Executive Vice Chair of Clinical Operations Section Head, Abdominal Imaging Wake Forest University School of Medicine;

More information

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,

More information

Mariska Leeflang Birmingham, 19 July 2016

Mariska Leeflang Birmingham, 19 July 2016 BiTE Biomarker and Test Evaluation Program Mariska Leeflang Birmingham, 19 July 2016 Consecutive series of patients Randomization Test A Test B Reference standard Reference standard Comparison of test

More information

Evaluation of Lung Cancer Response: Current Practice and Advances

Evaluation of Lung Cancer Response: Current Practice and Advances Evaluation of Lung Cancer Response: Current Practice and Advances Jeremy J. Erasmus I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of

More information

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination Poster No.: C-2317 Congress: ECR 2014 Type: Scientific Exhibit Authors:

More information

The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses

The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses Poster No.: C-1749 Congress: ECR 2014 Type: Scientific Exhibit Authors: U. Aksoy Ozcan 1, A. Öz 2, S.

More information

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer Jeon et al. Radiation Oncology (2019) 14:43 https://doi.org/10.1186/s13014-019-1246-8 RESEARCH Open Access Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and

More information

DVT Diagnosis. Reference methods. Whole leg Ultrasonography. Predictive values. Page 1. Diagnosis of 1 st time symptomatic DVT.

DVT Diagnosis. Reference methods. Whole leg Ultrasonography. Predictive values. Page 1. Diagnosis of 1 st time symptomatic DVT. DVT Diagnosis Ulf Nyman Associate Professor Lund University Department of Radiology East Division (Kristianstad, HässleholmH Trelleborg, Ystad) Sweden Diagnosis of 1 st time symptomatic DVT Scientific

More information

State-of-the-art of surgery for resectable primary tumors

State-of-the-art of surgery for resectable primary tumors Early colorectal cancer State-of-the-art of surgery for resectable primary tumors (Special focus on rectal cancer surgery) Stefan Heinrich & Hauke Lang Department of General, Visceral and University Hospital

More information

Prostate Cancer Local or distant recurrence?

Prostate Cancer Local or distant recurrence? Prostate Cancer Local or distant recurrence? Diagnostic flowchart Vanessa Vilas Boas Urologist VFX Hospital FEBU PSA - only recurrence PSA recurrence: 27-53% of all patients undergoing treatment with curative

More information

Current Clinical Practice. MR Imaging Evaluations. MRI Anatomic Review. Imaging to Address Clinical Challenges. Prostate MR

Current Clinical Practice. MR Imaging Evaluations. MRI Anatomic Review. Imaging to Address Clinical Challenges. Prostate MR BETH ISRAEL DEACONESS MEDICAL CENTER Prostate MR Neil M. Rofsky, MD Harvard Medical School Current Clinical Practice DIGITAL RECTAL EXAMINATION PSA ( ~ 20% False negative) BIOPSY (18-25% False negative)

More information

2015 복영증례 51/M C.C. Past Hx: DM, HTN (1998), Lab: WBC (11500/ μl ), CRP (0.71 mg/dl) 순천향서울병원황지영, 홍성숙 APCT (HAD #1) APCT (HAD#1) APCT (HAD #15)

2015 복영증례 51/M C.C. Past Hx: DM, HTN (1998), Lab: WBC (11500/ μl ), CRP (0.71 mg/dl) 순천향서울병원황지영, 홍성숙 APCT (HAD #1) APCT (HAD#1) APCT (HAD #15) Case 1 2015 복영증례 순천향서울병원황지영, 홍성숙 51/M C.C Abdominal pain and chilling (1 week ago) Diarrhea (a month ago) Past Hx: DM, HTN (1998), Alcoholic liver disease (2008) Lab: WBC (11500/ μl ), CRP (0.71 mg/dl)

More information

PSA and the Future. Axel Heidenreich, Department of Urology

PSA and the Future. Axel Heidenreich, Department of Urology PSA and the Future Axel Heidenreich, Department of Urology PSA and Prostate Cancer EAU Guideline 2011 PSA is a continuous variable PSA value (ng/ml) risk of PCa, % 0 0.5 6.6 0.6 1 10.1 1.1 2 17.0 2.1 3

More information

Tuberculosis and cancer

Tuberculosis and cancer Tuberculosis and cancer David P. Holland, MD, MHS Chief Clinical Officer, CDPB Fulton County Department of Health and Wellness Assistant Professor, Emory University Disclosures No relevant financial disclosures

More information

Methods of MR Fat Quantification and their Pros and Cons

Methods of MR Fat Quantification and their Pros and Cons Methods of MR Fat Quantification and their Pros and Cons Michael Middleton, MD PhD UCSD Department of Radiology International Workshop on NASH Biomarkers Washington, DC April 29-30, 2016 1 Disclosures

More information

Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality

Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality Sanoj Punnen, MD, MAS Assistant Professor of Urologic Oncology University of Miami, Miller School of Medicine and Sylvester

More information

Meta analysis in Rectal Cancer

Meta analysis in Rectal Cancer Meta analysis in Rectal Cancer Dr. Monica Irukulla Professor and Head Department of Radiation Oncology Nizam s Institute of Medical Sciences hyderabad Areas of meta analysis in rectal cancers Epidemiology

More information

Grandangolo in Radioterapia Oncologica. D. Genovesi; F. Perro/ Is1tuto di Radioterapia Oncologica CHIETI

Grandangolo in Radioterapia Oncologica. D. Genovesi; F. Perro/ Is1tuto di Radioterapia Oncologica CHIETI Grandangolo in Radioterapia Oncologica D. Genovesi; F. Perro/ Is1tuto di Radioterapia Oncologica CHIETI www.radioterapia.unich.it TOPICS ü ESOFAGO & GIUNZIONE ESOFAGO- GASTRICA ü STOMACO ü RETTO ü ANO

More information

Cancer du rectum et RCMI. Place de la radiothérapie de contact pour conserver. le rectum (T2, T3). J.P. GERARD. Monaco Monaco,

Cancer du rectum et RCMI. Place de la radiothérapie de contact pour conserver. le rectum (T2, T3). J.P. GERARD. Monaco Monaco, Cancer du rectum et RCMI. Place de la radiothérapie de contact pour conserver Centre Antoine Lacassagne Nice le rectum (T2, T3). J.P. GERARD Monaco 2-2-2018 Monaco, 02.02.2018 13 mn 1 DECLARATION D INTERET

More information

Innovations in Rectal Cancer Surgery

Innovations in Rectal Cancer Surgery Innovations in Rectal Cancer Surgery A. D Hoore MD PhD, EBSQ-CR, (hon)fascrs A. Wolthuis MD PhD, EBSQ-CR, FACS G. Bislenghi MD Departement of Abdominal Surgery University Hospitals Leuven, Belgium invasiveness

More information

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY

RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY COLORECTAL CLINICAL SUBGROUP RECTAL CANCER APPARENT COMPLETE RESPONSE (acr) AFTER LONG COURSE CHEMORADIOTHERAPY Finalised by: Dr Simon Gollins Mr Andrew Renehan Dr Mark Saunders Mr Nigel Scott Dr Shabbir

More information

بسم هللا الرحمن الرحيم. Prof soha Talaat

بسم هللا الرحمن الرحيم. Prof soha Talaat بسم هللا الرحمن الرحيم Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible

More information

Pat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP. Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research

Pat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP. Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research Pat Quigley,PhD,MPH,ARNP,CRRN,FAAN,FAANP Associate Director, VISN 8 Patient Safety Center Associate Chief for Nursing Service/Research E-Mail: patricia.quigley@med.va.gov 1 Overview Formulate measurable

More information

TUMOR HYPOXIA BENCH TO BEDSIDE

TUMOR HYPOXIA BENCH TO BEDSIDE TUMOR HYPOXIA BENCH TO BEDSIDE Marianne Nordsmark, Lise Saksø Mortensen, Morten Busk, Michael Horsman, Markus Alber, Niels Bassler, Jørgen Petersen and Jens Overgaard. Dept. Oncology, Aarhus University

More information

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain OUR APPROACH Incidental adrenal nodule/mass Isaac R Francis, M.B;B.S University of Michigan, Ann Arbor, Michigan Disclosures None (in memory) M Korobkin,

More information

Quantitative Imaging for Treatment Response Assessment. Thanks to 8/2/2017. Predicting response to RT or chemo can be based on:

Quantitative Imaging for Treatment Response Assessment. Thanks to 8/2/2017. Predicting response to RT or chemo can be based on: Quantitative Imaging for Treatment Response Assessment Amita Dave, Neelam Tyagi, Sang Ho Lee, Miria Crispin-Ortuzar, Jeho Jeong, John Humm, Milan Grkovski, Joe Deasy et al. Harini Veeraraghavan, PhD Jung

More information

Sentinel Lymph Node Biopsy in Other Tumours: Sentinel Lymph Node Biopsy in Other Tumours. Methodology. Results. Key Questions to Consider

Sentinel Lymph Node Biopsy in Other Tumours: Sentinel Lymph Node Biopsy in Other Tumours. Methodology. Results. Key Questions to Consider Sentinel Lymph Node Biopsy in Other Tumours Dr. Rona Cheifetz Surgical Oncology Update November 24, 2006 Sentinel Lymph Node Biopsy in Other Tumours: An Operation Looking for an Application Dr. Rona Cheifetz

More information

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine Overview Rationale for new imaging

More information

Diffusion Weighted Imaging in IBD: An Update Ethan A. Smith, MD

Diffusion Weighted Imaging in IBD: An Update Ethan A. Smith, MD Diffusion Weighted Imaging in IBD: An Update Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures Royalties from Elsevier

More information

ADJUVANT CHEMOTHERAPY FOR RECTAL CANCER

ADJUVANT CHEMOTHERAPY FOR RECTAL CANCER ESMO Preceptorship Programme Colorectal Cancer Barcelona November, 25-26, 2016 ADJUVANT CHEMOTHERAPY FOR RECTAL CANCER Andrés Cervantes Professor of Medicine OLD APPROACH TO RECTAL CANCER Surgical resection

More information

Adaptive radiation dose escalation in rectal adenocarcinoma: a review

Adaptive radiation dose escalation in rectal adenocarcinoma: a review Review Article Adaptive radiation dose escalation in rectal adenocarcinoma: a review Jonathan D. Van Wickle 1, Eric S. Paulson 1, Jerome C. Landry 2, Beth A. Erickson 1, William A. Hall 1 1 Department

More information

CHRISTIE COLORECTAL CANCER MDT FOLLOW-UP GUIDELINES

CHRISTIE COLORECTAL CANCER MDT FOLLOW-UP GUIDELINES CHRISTIE COLORECTAL CANCER MDT FOLLOW-UP GUIDELINES Following clinical complete response Circulated to Christie Colorectal MDT on 2 nd May 2018 For wider circulation to Colorectal Pathway Board 15 th May

More information

The added value of DW-MRI in characterization of tissue in treated head and neck tumors

The added value of DW-MRI in characterization of tissue in treated head and neck tumors ORIGINAL ARTICLE The added value of DW-MRI in characterization of tissue in treated head and neck tumors Lobna Rashed a, Shereen Elwan b, Laila Abdurrahman b, Lobna El Fiky c, Mohamed Shehata c, Reem Basyouni

More information

MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI

MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI Poster No.: C-1191 Congress: ECR 2010 Type: Educational Exhibit Topic: Genitourinary Authors: M. Takeuchi, K. Matsuzaki,

More information

CHAPTER 7 Concluding remarks and implications for further research

CHAPTER 7 Concluding remarks and implications for further research CONCLUDING REMARKS AND IMPLICATIONS FOR FURTHER RESEARCH CHAPTER 7 Concluding remarks and implications for further research 111 CHAPTER 7 Molecular staging of large sessile rectal tumors In this thesis,

More information

Prostate Biopsy in 2017

Prostate Biopsy in 2017 Prostate Biopsy in 2017 Bob Djavan, MD, PhD Professor and Chairman, Department of Urology, Rudolfinerhaus Foundation Hospital,Vienna, Austria Director Vienna Urology foundation Board member Scientific

More information